The nation is seeing a growing interest in mind-altering compounds , particularly N,N-Dimethyltryptamine and CBG . Scientists are increasingly examining the potential of these compounds for medical purposes, leading a nuanced conversation around their regulatory position and safe integration. Although limitations remain, the scientific community is